CN115594662A - Preparation method of (S) -nicotine - Google Patents
Preparation method of (S) -nicotine Download PDFInfo
- Publication number
- CN115594662A CN115594662A CN202211276431.1A CN202211276431A CN115594662A CN 115594662 A CN115594662 A CN 115594662A CN 202211276431 A CN202211276431 A CN 202211276431A CN 115594662 A CN115594662 A CN 115594662A
- Authority
- CN
- China
- Prior art keywords
- nicotine
- preparation
- molar ratio
- racemic
- inorganic base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title claims abstract description 53
- 229960002715 nicotine Drugs 0.000 title claims abstract description 53
- 229930182840 (S)-nicotine Natural products 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 40
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Chemical compound CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 23
- HDOUGSFASVGDCS-UHFFFAOYSA-N pyridin-3-ylmethanamine Chemical compound NCC1=CC=CN=C1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 238000006197 hydroboration reaction Methods 0.000 claims abstract description 6
- 230000003647 oxidation Effects 0.000 claims abstract description 6
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 6
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- -1 alcohol compound Chemical class 0.000 claims description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 150000007529 inorganic bases Chemical class 0.000 claims description 13
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- SXZIXHOMFPUIRK-UHFFFAOYSA-N diphenylmethanimine Chemical compound C=1C=CC=CC=1C(=N)C1=CC=CC=C1 SXZIXHOMFPUIRK-UHFFFAOYSA-N 0.000 claims description 11
- MYKUKUCHPMASKF-VIFPVBQESA-N (S)-nornicotine Chemical compound C1CCN[C@@H]1C1=CC=CN=C1 MYKUKUCHPMASKF-VIFPVBQESA-N 0.000 claims description 9
- MYKUKUCHPMASKF-UHFFFAOYSA-N Nornicotine Natural products C1CCNC1C1=CC=CN=C1 MYKUKUCHPMASKF-UHFFFAOYSA-N 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 claims description 9
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical group ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 8
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 230000029936 alkylation Effects 0.000 claims description 6
- 238000005804 alkylation reaction Methods 0.000 claims description 6
- 239000012022 methylating agents Substances 0.000 claims description 6
- 150000007522 mineralic acids Chemical class 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 claims description 6
- 239000012965 benzophenone Substances 0.000 claims description 5
- 239000003444 phase transfer catalyst Substances 0.000 claims description 5
- 150000003242 quaternary ammonium salts Chemical group 0.000 claims description 5
- 239000000010 aprotic solvent Substances 0.000 claims description 4
- XNYOSXARXANYPB-UHFFFAOYSA-N dicyclohexylborane Chemical compound C1CCCCC1BC1CCCCC1 XNYOSXARXANYPB-UHFFFAOYSA-N 0.000 claims description 4
- 230000002140 halogenating effect Effects 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 239000011630 iodine Substances 0.000 claims description 4
- 229960001922 sodium perborate Drugs 0.000 claims description 4
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 claims description 4
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- CHQVQXZFZHACQQ-UHFFFAOYSA-M benzyl(triethyl)azanium;bromide Chemical compound [Br-].CC[N+](CC)(CC)CC1=CC=CC=C1 CHQVQXZFZHACQQ-UHFFFAOYSA-M 0.000 claims description 3
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 claims description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 3
- UQFSVBXCNGCBBW-UHFFFAOYSA-M tetraethylammonium iodide Chemical compound [I-].CC[N+](CC)(CC)CC UQFSVBXCNGCBBW-UHFFFAOYSA-M 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- ZGFPIGGZMWGPPW-UHFFFAOYSA-N formaldehyde;formic acid Chemical compound O=C.OC=O ZGFPIGGZMWGPPW-UHFFFAOYSA-N 0.000 claims description 2
- 230000001035 methylating effect Effects 0.000 claims description 2
- 238000009776 industrial production Methods 0.000 abstract description 10
- 238000007069 methylation reaction Methods 0.000 abstract description 5
- 230000011987 methylation Effects 0.000 abstract description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 abstract 1
- 238000005937 allylation reaction Methods 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 54
- 239000012074 organic phase Substances 0.000 description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 238000001914 filtration Methods 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 11
- 238000001035 drying Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 239000003480 eluent Substances 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 239000003208 petroleum Substances 0.000 description 8
- 238000006722 reduction reaction Methods 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000208125 Nicotiana Species 0.000 description 5
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 5
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- XBLVHTDFJBKJLG-UHFFFAOYSA-N Ethyl nicotinate Chemical compound CCOC(=O)C1=CC=CN=C1 XBLVHTDFJBKJLG-UHFFFAOYSA-N 0.000 description 4
- 239000007818 Grignard reagent Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 150000004795 grignard reagents Chemical class 0.000 description 4
- 229910052741 iridium Inorganic materials 0.000 description 4
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- NYPYPOZNGOXYSU-UHFFFAOYSA-N 3-bromopyridine Chemical compound BrC1=CC=CN=C1 NYPYPOZNGOXYSU-UHFFFAOYSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 229940064982 ethylnicotinate Drugs 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000013341 scale-up Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- SNICXCGAKADSCV-SNVBAGLBSA-N (+)-nicotine Chemical compound CN1CCC[C@@H]1C1=CC=CN=C1 SNICXCGAKADSCV-SNVBAGLBSA-N 0.000 description 1
- 229930182841 (R)-nicotine Natural products 0.000 description 1
- FMAQXEBCTUCOBO-UHFFFAOYSA-N 1-but-1-enylpyrrolidin-2-one Chemical compound CCC=CN1CCCC1=O FMAQXEBCTUCOBO-UHFFFAOYSA-N 0.000 description 1
- KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 1
- CESUXLKAADQNTB-SSDOTTSWSA-N 2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@](N)=O CESUXLKAADQNTB-SSDOTTSWSA-N 0.000 description 1
- OIPHWUPMXHQWLR-UHFFFAOYSA-N 2-pyridin-3-ylacetonitrile Chemical compound N#CCC1=CC=CN=C1 OIPHWUPMXHQWLR-UHFFFAOYSA-N 0.000 description 1
- DOQLCJMCQWQQHK-UHFFFAOYSA-N 4-chlorobutanal Chemical compound ClCCCC=O DOQLCJMCQWQQHK-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002027 dichloromethane extract Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012418 sodium perborate tetrahydrate Substances 0.000 description 1
- IBDSNZLUHYKHQP-UHFFFAOYSA-N sodium;3-oxidodioxaborirane;tetrahydrate Chemical compound O.O.O.O.[Na+].[O-]B1OO1 IBDSNZLUHYKHQP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- CESUXLKAADQNTB-UHFFFAOYSA-N tert-butanesulfinamide Chemical compound CC(C)(C)S(N)=O CESUXLKAADQNTB-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
The invention discloses a preparation method of (S) -nicotine, which takes 3-pyridine methylamine as a reaction raw material, converts the 3-pyridine methylamine into racemic nicotine through phase transfer allylation, hydroboration oxidation, cyclization and methylation, and then obtains the (S) -nicotine with high optical purity through L-tartrate resolution. The method has the advantages of simple and easy operation, cheap and easily-obtained reagents, green and environment-friendly reaction process, high purity and yield of the product nicotine, and suitability for industrial production.
Description
Technical Field
The invention belongs to the technical field of fine chemical engineering, and particularly relates to a method for preparing (S) -nicotine by using 3-pyridylmethylamine as a raw material.
Background
Nicotine (the english name Nicotine, the chemical name is 1-methyl-2- (3' -pyridine) pyrrolidine), also known as Nicotine, and natural Nicotine is in (S) -configuration. In 1828, (S) -nicotine was first extracted from tobacco leaves by the German chemists Posselt and Reimann. In 1843, melsens determined the nicotine chemical formula. In 1893, pinner determined nicotine structure. In 1904, nicotine was first synthesized by Pictet and Crepieux.
Nicotine is a key component of tobacco alkaloid and has wide application in tobacco related products. Meanwhile, nicotine and its derivatives, nicotinic acid, nicotinamide, nicotinate, etc., have various physiological activities, such as the effects of treating depression, anxiety, alzheimer's disease, parkinson's disease, epilepsy and other nerve diseases.
However, the source of (S) -nicotine mainly depends on the extraction and purification of plant components such as tobacco, and this method is subject to great uncertainty, not only by the quality and source of tobacco, but also by the control of relevant policies. Therefore, the development of the artificial synthesis method of (S) -nicotine with industrial production potential has important application value.
Patents and literature on nicotine synthesis, document j. Org. Chem. 1990, 55 (6), 1736-1744, report the synthesis of racemic nicotine in four steps starting from pyrrolidine, as shown in the following formula:
the reference relates to a very dangerous reagent of tert-butyl lithium and reaction conditions of-120 ℃, and meanwhile, the noble metal is adopted for reduction, so that the production cost is high, and the industrial production is not facilitated.
Patent document US 2010209006A1 reports a process for the preparation of racemic nicotine starting from methyl nicotinate via a four-step reaction, as shown in the following formula:
the route requires the use of sodium hydride, a hazardous reagent, and the N-butenyl pyrrolidone used in the route is relatively expensive and is not suitable for industrial scale-up.
Patent document CN 110357853B provides a synthesis method of racemic nicotine, which comprises preparing grignard reagent of 3-bromopyridine from 3-bromopyridine and magnesium chips, adding N-methylpyrrolidone into the system to obtain enamine intermediate, and then performing reduction reaction in the presence of metal reduction catalysts such as Pd/C, pt/C and raney nickel to obtain racemic nicotine, as shown in the following formula:
the route needs to use a Grignard reagent, relates to reaction conditions such as noble metal reduction and the like, and has high cost and is not beneficial to industrial scale-up production.
Patent document CN 111511726a reports a method for preparing (S) -nicotine, which comprises reacting racemic nicotine with ethyl nicotinate and N-vinyl pyrrolidone in four steps, and further resolving it with dibenzoyl tartaric acid to obtain (S) -nicotine:
the route has the disadvantages of complicated steps, long production period and high production cost.
Document j, am. chem, soc. 2015, 137 (1), 90-93 and patent document CN 104341390a establish a highly efficient asymmetric hydrogenation reaction using a cyclic imine of a pyridyl moiety and an iridium catalyst of a chiral spirophosphine-oxazoline ligand to obtain (S) -nicotine;
the iridium metal catalyst used in the route is expensive and complex to prepare, and is not beneficial to industrial production.
Patent document CN 113896713A reports asymmetric reduction using a metal iridium catalyst, followed by methylation to obtain (S) -nicotine;
the iridium catalyst used in the route is expensive and complex in preparation, and is not beneficial to industrial production.
Patent document CN 114671852a reports a method for preparing optically pure (S) -nicotine, which uses ethyl nicotinate and N-vinyl pyrrolidone as raw materials, and performs enantioselective reduction and methylation reaction by imine reductase to obtain (S) -nicotine;
the route uses flammable and difficult-to-store sodium metal, so that the reaction conditions are harsh and the operation is dangerous; the enzyme is used for reduction, the reaction time is long, the enzyme is not easy to store and is easy to inactivate, and the method is not suitable for industrial production.
Patent document CN 113979993A reports a method for preparing optically pure (S) -nicotine, in which 3-pyridinecarboxaldehyde and (R) -tert-butylsulfinamide are condensed in the presence of a catalytic substance to obtain chiral imine, thereby obtaining (S) -nicotine;
the circuit is complex, the production cost is high, the yield is low, and the industrial production is not facilitated.
Patent document CN114437029a reports a method for preparing optically pure (S) -nicotine, in which 3-bromopyridine and magnesium or n-butyllithium are used to prepare grignard reagent or lithium reagent, 4-chlorobutanal and chiral tert-butyl sulfinamide are reacted, and (R) -nicotine and (S) -nicotine are prepared through cyclization and methylation;
the route uses Grignard reagent or lithium reagent with harsh reaction conditions, so the reaction is dangerous and is not beneficial to industrial production.
Patent CN 113999201a reports a method for preparing optically pure (S) -nicotine, which uses 3-pyridine acetonitrile as a raw material, and pyrrolidone for reaction, and then palladium catalysis and ligand for asymmetric reduction to prepare (S) -nicotine.
This route uses a palladium catalyst and expensive ligands and is not suitable for industrial production.
Disclosure of Invention
The invention provides a method for preparing (S) -nicotine by taking 3-pyridine methylamine as a raw material, which comprises the following steps:
the method takes 3-pyridine methylamine and benzophenone or benzophenone imine as raw materials to obtain 3-pyridine methylamine benzophenone imine; 3-pyridine methylamine benzophenone imine and allyl bromide are subjected to alkylation under the condition of inorganic base and phase transfer catalyst; then (S) -nicotine is obtained through hydroboration oxidation, hydrolysis, halogenation, cyclization, methylation and resolution.
The method comprises the following specific processes:
(1) In the presence of a solvent, 3-pyridine methylamine and benzophenone or benzophenone imine are used as raw materials and react for 6 to 24h at the temperature of 25 to 100 ℃ to prepare 3-pyridine methylamine benzophenone imine;
the molar ratio of the 3-pyridine methylamine to the benzophenone or the benzophenone imine is 1.2 to 1;
(2) In an aprotic solvent, 3-pyridine methylamine benzophenone imine and allyl bromide are taken as raw materials, inorganic base and a phase transfer catalyst are added, and the reaction is carried out for 1 to 8 hours at the temperature of 15 to 25 ℃ to prepare an alkylation product;
the aprotic solvent is one of toluene, dichloromethane and chloroform; the inorganic base is one of potassium carbonate, sodium hydroxide, potassium hydroxide and cesium hydroxide, the molar ratio of the inorganic base to 3-pyridylmethylamine benzophenone imine is 3 to 1 to 6, the phase transfer catalyst is quaternary ammonium salt (comprising tetrabutylammonium bromide, tetrabutylammonium hydroxide, tetraethylammonium iodide and benzyltriethylammonium bromide), the molar ratio of the quaternary ammonium salt to 3-pyridylmethylamine benzophenone imine is 1 to 5 to 1, and the molar ratio of allyl bromide to 3-pyridylmethylamine benzophenone imine is 1 to 1.8;
(3) Carrying out hydroboration oxidation on the alkylation product at the temperature of 10 to 40 ℃ to prepare an alcohol compound;
the hydroboration oxidation is realized in one of a dicyclohexylborane and sodium perborate system, a sodium borohydride-iodine system and a 30% hydrogen peroxide solution; wherein the molar ratio of dicyclohexylborane to sodium perborate in the dicyclohexylborane and sodium perborate system is 1:3, and the molar ratio of sodium borohydride to iodine in the sodium borohydride-iodine system is 2:1;
(4) Adding inorganic acid into an alcohol compound to remove a benzophenone protecting group, then adding a halogenating reagent, chlorinating at 20-80 ℃, and then adding inorganic base for cyclization to prepare racemic nornicotine;
the inorganic acid is 3mol/L dilute hydrochloric acid or 1mol/L dilute sulfuric acid; the molar ratio of the alcohol compound to the inorganic acid is 1 to 1; the inorganic base is one of sodium carbonate and potassium carbonate; the molar ratio of the alcohol compound to the inorganic base is 1 to 5 to 1; the halogenating agent is thionyl chloride;
(5) Methylating racemic nornicotine with a methylating agent to obtain racemic nicotine;
the methylating agent is a formic acid-formaldehyde mixture or methyl iodide; the molar ratio of racemic nornicotine to methylating agent is 1 to 2 to 1;
(6) Resolving racemic nicotine with dibenzoyl-L-tartrate to obtain (S) -nicotine; the mass ratio of the racemic nicotine to the dibenzoyl-L-tartrate is 1 to 1.
The invention has the advantages and technical effects that:
1. the method is simple and easy to operate, and the reagent is cheap and easy to obtain;
2. the reaction process is green and environment-friendly;
3. the product nicotine has high purity and yield, and is suitable for industrial production.
Drawings
FIG. 1 is a NMR spectrum of (S) -nicotine obtained in example 1;
fig. 2 is a liquid chromatography spectrum of racemic nicotine (a) and (S) -nicotine (b).
Detailed Description
The method of the present invention is further described below by way of examples, but the scope of the present invention is not limited by the examples, and the reagents used in the examples are all conventional commercially available reagents or reagents prepared by conventional methods without specific descriptions, and the methods used are all conventional methods without specific descriptions.
Example 1: the preparation method of (S) -nicotine is as follows
1. Adding 15mL of toluene into a 25mL round-bottom flask, adding 1.30.30 mL (13.2 mmol) of 3-pyridinemethylamine and 2.5g (14.0 mmol) of benzophenone under stirring, reacting overnight at 100 ℃, monitoring the reaction process by TLC, adding 40mL of water after the reaction is finished, extracting three times by using 30mL of ethyl acetate, collecting combined organic phases, drying by using anhydrous magnesium sulfate, filtering, concentrating the organic phase under reduced pressure, separating by using silica gel column chromatography, eluting by using petroleum ether-ethyl acetate mixed liquor with volume ratios of 20;
2. adding 15mL of toluene into a 25mL round-bottom flask, adding 0.3g (1 mmol) of tetrabutylammonium bromide and 2.6g (66 mmol) of sodium hydroxide under stirring, adding 3g (11 mmol) of 3-pyridylmethylaminobenzophenoneimine, finally dropwise adding 1.14mL (13 mmol) of allyl bromide, reacting at 20 ℃, monitoring the reaction process by TLC, adding 40mL of water after the reaction is finished, extracting three times by using 40mL of ethyl acetate, collecting the combined organic phases, drying by using anhydrous magnesium sulfate, filtering, concentrating the organic phase under reduced pressure, performing alumina column chromatography, sequentially eluting by using petroleum ether-ethyl acetate mixed liquor with the volume ratio of 20 to 10, collecting eluent with the volume ratio of 10 to obtain an alkylation product, wherein the yield is 92%;
3. reacting BH 3 . SMe 2 Adding 9.6mL (19.2 mmol) of an alkylated product into a tetrahydrofuran solution of cyclohexene at 0 ℃ in an amount of 4mL (38.4 mmol) after stirring for 3h, adding 2g (6.4 mmol) of the alkylated product into the reaction solution, stirring at 25 ℃ for 20 h, adding water (20 mL) and sodium perborate tetrahydrate (5.9 g) into the obtained reaction solution, reacting at 10 ℃, monitoring the reaction progress by TLC, adding 50mL of water to dilute the reaction after the reaction is finished, adding 50mL of water, extracting with 40mL of ethyl acetate for three times, collecting the combined organic phases, drying with anhydrous magnesium sulfate, filtering, concentrating the organic phase under reduced pressure, separating by silica gel column chromatography, eluting with petroleum ether containing 80% of ethyl acetate, ethyl acetate and ethyl acetate containing 5% of methanol in turn, collecting the eluent eluted with ethyl acetate containing 5% of methanol to obtain an alcohol compound with a yield of 88%;
4. the resulting 2g (5.2 mmol) of the alcohol compound was dissolved in 3mol/L HCl (15 mL) and Et 2 O (15 mL), the obtained mixture is stirred vigorously for 30min at 20 ℃, after the reaction is finished, an aqueous layer is reserved, an organic layer is discarded, the obtained aqueous layer is concentrated under reduced pressure to obtain colorless oily liquid, thionyl chloride (15 mL) is added into the colorless oily liquid, the mixture is stirred for 30min at 20 ℃, then white solid obtained after vacuum concentration is placed into acetonitrile (80 mL) to react with 5g (47 mmol) of excessive sodium carbonate at 25 ℃, the reaction process is monitored, after the reaction is finished, 50mL of water is added, ethyl acetate 40mL is used for extraction for three times, the combined organic phase is collected and dried by anhydrous magnesium sulfate, the filtration is carried out, the organic phase is concentrated under reduced pressure, the organic phase is separated by silica gel column chromatography, the dichloromethane containing 3% of methanol and 1% of triethylamine is used for elution, the eluent is collected, and the yield of racemic nicotine is 82%;
5. dissolving 2.5g (0.01 mol) of racemic nornicotine in 10mL of ethanol, slowly adding 10g of formic acid aqueous solution (35 mass percent and containing 0.15mol of formic acid) and 6.5g of formaldehyde aqueous solution (35 mass percent and containing 0.15mol of formaldehyde) in ice bath, heating to 60 ℃ for reaction for 1h, adjusting the pH value of the system to 12-14 by using sodium hydroxide aqueous solution (30 mass percent), extracting by using toluene, collecting and combining organic phases, drying by using anhydrous magnesium sulfate, filtering, concentrating the organic phases under reduced pressure to obtain a racemic nicotine crude product, performing silica gel column chromatography separation, eluting by using dichloromethane containing 3 percent of methanol and 1 percent of triethylamine, collecting eluent to obtain a racemic nicotine pure product, wherein the yield is 98 percent, and is shown in figure 2a;
6. dissolving 5g of racemic nicotine and 11g of dibenzoyl-L-tartrate in 50mL of absolute ethanol, refluxing the mixture at 80 ℃ for 30min, cooling to 25 ℃, stirring for 12 h, separating out and filtering to obtain a precipitate, suspending the precipitate in 30mL of water and 30mL of toluene, dropwise adding ammonia to adjust the pH to 9-10, after phase separation, collecting a water phase, extracting twice with toluene, collecting and combining toluene phases, and concentrating under reduced pressure to obtain pure (S) -nicotine with the yield of 78%, wherein the yield of the pure (S) -nicotine is nuclear magnetic resonance hydrogen spectrum (600 MHz, CDCl and CDCl) 3 ) See fig. 1, 2b.
Example 2: the preparation method of (S) -nicotine is as follows
1. Adding 15mL of dichloromethane into a 25mL round-bottom flask, adding 1.30mL (13.2 mmol) of 3-picolylamine and 1.82mL (11.0 mmol) of benzophenone imine under stirring, reacting at 25 ℃, monitoring the reaction process by TLC (thin layer chromatography), adding 30mL of water after the reaction is finished, extracting with 30mL of ethyl acetate for three times, collecting and combining organic phases, drying by anhydrous magnesium sulfate, filtering, concentrating the organic phase under reduced pressure, cooling and crystallizing the product in petroleum ether, filtering, collecting crystals, and drying to obtain 3-picolylamine benzophenone imine with the yield of 98%;
2. adding 15mL of dichloromethane into a 25mL round-bottom flask, adding 0.6g (2 mmol) of benzyltriethylammonium bromide and 4.56g (33 mmol) of potassium hydroxide under stirring, adding 3g (11 mmol) of 3-pyridylmethylaminobenzophenonimine, finally dropwise adding 1.3mL (15 mmol) of allyl bromide, reacting at 25 ℃, monitoring the reaction process by TLC, adding 40mL of water after the reaction is finished, extracting three times by using 40mL of ethyl acetate, collecting combined organic phases, drying by using anhydrous magnesium sulfate, filtering, concentrating the organic phase under reduced pressure, separating by using silica gel column chromatography, sequentially eluting by using petroleum ether-ethyl acetate mixed liquor with the volume ratio of 10 to 5:1, collecting 5:1 eluent to obtain an alkylated product with the yield of 90%;
3. weighing 2.4g (63 mmol) of sodium borohydride, placing the sodium borohydride in a round-bottom flask, adding 10mL of tetrahydrofuran, and adding I under ice bath 2 Dripping tetrahydrofuran solution containing 2g (6.4 mmol) of alkylated product into the reaction solution, reacting at 40 deg.C, monitoring the reaction process, and after the reaction is finishedAdding 1mol/L sodium hydroxide solution slowly into a reaction bottle, quickly adding 30 mass percent hydrogen peroxide solution into reaction liquid, adding 40mL water after the reaction is finished, extracting with 40mL ethyl acetate for three times, combining organic phases, drying with anhydrous magnesium sulfate, filtering, decompressing and concentrating the organic phases, separating by silica gel column chromatography, eluting with petroleum ether containing 80 percent ethyl acetate, ethyl acetate and ethyl acetate containing 5 percent methanol in sequence, collecting the eluent of the ethyl acetate containing 5 percent methanol to obtain an alcohol compound with the yield of 78 percent;
4. 1g (2.6 mmol) of the alcohol compound was dissolved in 1mol/L dilute sulfuric acid (10 mL) and Et 2 O (10 mL), and the resulting mixture was stirred vigorously at 25 ℃ for 30min, and the resulting aqueous layer was separated and concentrated to give a colorless oily liquid; then stirring 1h of the colorless oily liquid in thionyl chloride (8 mL) at 80 ℃, then placing a white solid obtained by vacuum concentration in acetonitrile (80 mL) to react with excessive potassium carbonate 1.8g (13 mmol) at 25 ℃, monitoring the reaction process, after the reaction is finished, adding 30mL of water, extracting with 30mL of ethyl acetate for three times, combining organic phases, drying with anhydrous magnesium sulfate, filtering, concentrating the organic phase under reduced pressure, separating by silica gel column chromatography, eluting with dichloromethane containing 3% of methanol and 1% of triethylamine, collecting eluent to obtain racemic nornicotine, wherein the yield is 77%;
5. dissolving 5g (0.02 mol) of racemic nornicotine in 10mL of dichloromethane, adding 5.68 g (0.04 mol) of methyl iodide and 4.25 mL (0.03 mol) of triethylamine at room temperature, continuously reacting at 25 ℃ for 5 h, adjusting the pH value of a system to 12-14 by using an aqueous solution of sodium hydroxide (30 mass percent), standing for layering, removing an organic layer, extracting a water layer by using dichloromethane, evaporating dichloromethane extract under reduced pressure to dryness to obtain a crude racemic nicotine product, distilling at 130 ℃ under reduced pressure, collecting the fraction to obtain a pure racemic nicotine product, wherein the yield is 90%;
6. in step 6 of example 1, the yield of (S) -nicotine was 78%.
Example 3: the preparation method of (S) -nicotine is as follows
1. Same as example 1, step 1;
2. adding 10mL of dichloromethane into a 25mL round-bottom flask, adding 0.38 g (1.46 mmol) of tetrabutylammonium hydroxide and 3.70g (22 mmol) of cesium hydroxide under stirring, adding 2g (7.3 mmol) of 3-pyridylmethylamine benzophenone imine, finally dropwise adding 1.14mL (13 mmol) of allyl bromide, reacting at 25 ℃, monitoring the reaction process, adding 30mL of water after the reaction is finished, extracting three times by using 30mL of ethyl acetate, collecting the combined organic phases, drying by using anhydrous magnesium sulfate, filtering, concentrating the organic phase under reduced pressure, separating by using a silica gel column chromatography, sequentially eluting by using petroleum ether-ethyl acetate mixed liquor with a volume ratio of 10 to 5:1, collecting 5:1 eluent to obtain an alkylated product, wherein the yield is 89%;
steps 3-6 are the same as steps 3-6 of example 1, pure (S) -nicotine, yield 75%.
Example 4: the preparation method of (S) -nicotine is as follows
1. Same as example 2, step 1;
2. 20mL chloroform was added to a 50mL round bottom flask, tetraethylammonium iodide 0.47 g (1.8 mmol) and potassium carbonate 5.14 g (37 mmol) were added with stirring, 3-pyridylmethylamine benzophenone imine 5g (18.3 mmol) was added, finally allyl bromide 2.58 mL (33 mmol) was added dropwise, the reaction was monitored at 25 ℃. After the reaction is finished, 50mL water is added, extraction is carried out for three times by using 50mL ethyl acetate, organic phases are combined and dried by anhydrous magnesium sulfate, filtration is carried out, the organic phase is concentrated under reduced pressure and separated by alumina column chromatography, elution is carried out by using petroleum ether-ethyl acetate mixed liquor with the volume ratio of 20 to 10.
Steps 3-6 are the same as steps 3-6 of example 2, pure (S) -nicotine, yield 78%.
Claims (6)
1. A process for the preparation of (S) -nicotine, characterized by the steps of:
(1) 3-pyridine methylamine and benzophenone or benzophenone imine are taken as raw materials and react for 6 to 24h at the temperature of 25 to 100 ℃ to prepare 3-pyridine methylamine benzophenone imine;
(2) In an aprotic solvent, 3-pyridine methylamine benzophenone imine and allyl bromide are taken as raw materials, inorganic base and a phase transfer catalyst are added, and the reaction is carried out for 1 to 8 hours at the temperature of 15 to 25 ℃ to prepare an alkylation product;
(3) Subjecting the alkylation product to hydroboration oxidation at 10 to 40 ℃ to prepare an alcohol compound;
(4) Adding inorganic acid into an alcohol compound to remove a benzophenone protecting group, then adding a halogenating reagent, chlorinating at 20-80 ℃, and then adding inorganic base for cyclization to prepare racemic nornicotine;
(5) Methylating racemic nornicotine with a methylating agent to obtain racemic nicotine;
(6) Resolving racemic nicotine with dibenzoyl-L-tartrate to obtain (S) -nicotine;
2. a process for the preparation of (S) -nicotine according to claim 1, characterized in that: the aprotic solvent in the step (2) is one of toluene, dichloromethane and chloroform; the inorganic base is one of potassium carbonate, sodium hydroxide, potassium hydroxide and cesium hydroxide, the molar ratio of the inorganic base to the 3-pyridinemethylamine benzophenone imine is 3 to 1, the phase transfer catalyst is a quaternary ammonium salt, the molar ratio of the quaternary ammonium salt to the 3-pyridinemethylamine benzophenone imine is 1 to 5 to 1, and the molar ratio of allyl bromide to the 3-pyridinemethylamine benzophenone imine is 1 to 1.8.
3. A process for the preparation of (S) -nicotine according to claim 2, characterized in that: the quaternary ammonium salt is one of tetrabutylammonium bromide, tetrabutylammonium hydroxide, tetraethylammonium iodide and benzyltriethylammonium bromide.
4. A process for the preparation of (S) -nicotine according to claim 1, characterized in that: the hydroboration oxidation in the step (3) is realized in one of a dicyclohexylborane and sodium perborate system, a sodium borohydride-iodine system and a 30% hydrogen peroxide solution, and the halogenating agent is thionyl chloride.
5. A process for the preparation of (S) -nicotine according to claim 1, characterized in that: in the step (4), the inorganic acid is 3mol/L dilute hydrochloric acid or 1mol/L dilute sulfuric acid; the molar ratio of the alcohol compound to the inorganic acid is 1 to 1; the inorganic base is one of sodium carbonate and potassium carbonate; the molar ratio of the alcohol compound to the inorganic base is 1 to 5 to 1.
6. A process for the preparation of (S) -nicotine according to claim 1, characterized in that: the methylating agent in the step (5) is a formic acid-formaldehyde mixture or methyl iodide; the molar ratio of racemic nornicotine to methylating agent is 1 to 2 to 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211276431.1A CN115594662A (en) | 2022-10-19 | 2022-10-19 | Preparation method of (S) -nicotine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211276431.1A CN115594662A (en) | 2022-10-19 | 2022-10-19 | Preparation method of (S) -nicotine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115594662A true CN115594662A (en) | 2023-01-13 |
Family
ID=84849738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211276431.1A Pending CN115594662A (en) | 2022-10-19 | 2022-10-19 | Preparation method of (S) -nicotine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115594662A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114702475A (en) * | 2022-05-17 | 2022-07-05 | 大连天源基化学有限公司 | Synthesis process of single-configuration nicotine |
CN116217544A (en) * | 2023-05-08 | 2023-06-06 | 济南悟通生物科技有限公司 | Synthesis method of (S) -nornicotine |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011119722A2 (en) * | 2010-03-23 | 2011-09-29 | Rock Creek Pharmaceuticals, Inc. | Use of anatabine to treat inflammation and methods of synthesizing anatabine |
CN107286132A (en) * | 2017-05-27 | 2017-10-24 | 宁波智锐新材料有限公司 | A kind of preparation method for anatabine |
CN111511726A (en) * | 2017-12-22 | 2020-08-07 | 斯福瑞股份有限公司 | Preparation of racemic nicotine by reaction of ethyl nicotinate with N-vinylpyrrolidone in the Presence of an alcoholate base and subsequent processing steps |
-
2022
- 2022-10-19 CN CN202211276431.1A patent/CN115594662A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011119722A2 (en) * | 2010-03-23 | 2011-09-29 | Rock Creek Pharmaceuticals, Inc. | Use of anatabine to treat inflammation and methods of synthesizing anatabine |
CN107286132A (en) * | 2017-05-27 | 2017-10-24 | 宁波智锐新材料有限公司 | A kind of preparation method for anatabine |
CN111511726A (en) * | 2017-12-22 | 2020-08-07 | 斯福瑞股份有限公司 | Preparation of racemic nicotine by reaction of ethyl nicotinate with N-vinylpyrrolidone in the Presence of an alcoholate base and subsequent processing steps |
Non-Patent Citations (3)
Title |
---|
DEO, NIRANJAN M等: "Regioselective alkylation of N-(diphenylmethylidine)-3-(aminomethyl)pyridine: a simple route to minor tobacco alkaloids and related compounds", TETRAHEDRON LETTERS, vol. 37, no. 8, pages 1137 - 1140, XP004030090, DOI: 10.1016/0040-4039(96)00002-0 * |
GIANFRANCO CAINELLI等: "Efficient Transamination under Mild Conditions: Preparation of Primary Amine Derivatives from Carbonyl Compounds via Imine Isomerization with Catalytic Amounts of Potassium tert-Butoxide", J.ORG.CHEM., vol. 61, pages 5134 - 5139 * |
XIAOYAN QIAN等: "Palladium-Catalyzed Decarboxylative Generation and Asymmetric Allylation of α-Imino Anions", ORGANIC LETTERS, vol. 16, pages 5228 - 5231 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114702475A (en) * | 2022-05-17 | 2022-07-05 | 大连天源基化学有限公司 | Synthesis process of single-configuration nicotine |
CN114702475B (en) * | 2022-05-17 | 2023-12-26 | 大连天源基化学有限公司 | Synthesis process of nicotine with single configuration |
CN116217544A (en) * | 2023-05-08 | 2023-06-06 | 济南悟通生物科技有限公司 | Synthesis method of (S) -nornicotine |
CN116217544B (en) * | 2023-05-08 | 2023-08-29 | 济南悟通生物科技有限公司 | Synthesis method of (S) -nornicotine |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115594662A (en) | Preparation method of (S) -nicotine | |
EP3925955A1 (en) | Method for asymmetrically preparing nicotine | |
CN111704573B (en) | Preparation method of rabeprazole chloride and intermediate thereof | |
WO2005044805A1 (en) | A novel process for preparing donepezil and its derivatives | |
CN114702475A (en) | Synthesis process of single-configuration nicotine | |
CN115073251B (en) | Asymmetric catalytic synthesis method of nicotine | |
CN113979993A (en) | Method for asymmetric synthesis of (S) -nicotine | |
CN113185465A (en) | Preparation method of 4-ethyl-5-aminopyrimidine | |
CN114230553A (en) | Asymmetric synthesis method of levo-nicotine | |
CN110937985A (en) | Synthetic method of paradol | |
CN114213460B (en) | Chiral nitrogen-phosphine compound for ketone asymmetric hydrogenation reaction or transfer hydrogenation reaction, preparation method and application | |
CN112250567B (en) | Synthetic method of AMG837 and chiral gamma-methyl phenylpentanol | |
Ren et al. | Arylamine synthesis enabled by a photocatalytic skeletal-editing dehydrogenative aromatization strategy | |
WO2005076749A2 (en) | A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine | |
CN110790708B (en) | Preparation method of Ailixipine intermediate | |
CN112645984B (en) | Half-sandwich ruthenium complex containing phenyl benzoxazole structure and preparation method and application thereof | |
CN113788784B (en) | Preparation method of 2-fluoro-3-trifluoromethyl pyridine | |
CN109651437A (en) | A kind of chiral nitrogen phosphorus ligand and preparation method thereof and a kind of method for splitting racemization menthol | |
CN115650824B (en) | Chiral diol and preparation method thereof, prepared catalyst and preparation method and application thereof | |
CN114085130B (en) | Method for synthesizing ((1R,8S,9S, Z) -bicyclo [6.1.0] non-4-en-9-yl) methanol | |
WO2023007712A1 (en) | (r,s)-nicotine production method | |
CN114262290B (en) | 4-methylene pyrrolidine-2-thioketone compound, and synthetic method and application thereof | |
CN112300059B (en) | Preparation method of PF-06651600 intermediate | |
CN116478052A (en) | Method for synthesizing 1-naphthylamine derivative by copper catalysis | |
CN112375101A (en) | Method for preparing chiral nitrogen-phosphorus ligand L-8 containing pyridocyclohexane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |